Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Drug Discovery > World Drug Discovery Technologies Markets Outlook
Category
Pharmaceutical (4988)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (561)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

World Drug Discovery Technologies Markets Outlook

Published by Frost & Sullivan
Published November, 2006 Product code 47086
Content info 94 pages
Price
US $ 10000 Web Access (Regional License)
US $ 10500 Web Access (Regional License) & Hard Copy


World Drug Discovery Technologies Markets Outlook published by Frost & Sullivan in November, 2006. This report consists of 94 pages and the price starts from US $ 10000.

Introduction

Abstract

The World Drug Discovery Technologies market is a dynamic marketplace with substantial opportunity. This study focuses on the market dynamics of 2005, by looking at the four major contributors to this market: top 20 pharmaceutical companies, biotechnology companies, top 5 agribiotech companies, and the NIH budget. The study also provides detailed analysis of the top competitors in the research products market, as well as those who have been affected by changing market dynamics.

Table of Contents

1 WORLD DRUG DISCOVERY TECHNOLOGIES OUTLOOK

  • Introduction
    • Introduction
    • Disclaimer
    • Certification
    • Research Scope and Methodology
  • Market Overview
    • Outline I
    • Market Segmentation
    • Drug Discovery Process
    • Clinical Trials Process
    • Market Challenges
    • Technology and Product Trends
    • Challenges and Strategies
  • Overview of Drug Discovery Technologies Market
    • Outline II
    • Who are the Top 15 Vendors?
    • Market Positioning
    • Where did 2005 Growth Come From?
    • Consumers of Research Products
    • Future Market Growth
    • Key Factors Facing Consumers
    • Market Revenue Analysis
    • Research Products Market Forecasts
    • Research Products Market Forecasts by Segment
  • Top 15 Pharmaceutical Spending
    • Outline III
    • Market Share of Top 15 Pharmaceutical Companies
    • Top 15 Pharmaceutical Companies- Revenue Forecasts
    • Top 15 Pharmaceutical Companies- R&D Spending Forecasts
    • Pre-clinical Spending- Top 15 Pharmaceutical Companies
  • Biotechnology Spending
    • Outline IV
    • Drug Discovery Biotechnology Market Share
    • Drug Discovery Biotechnology- Revenue Forecasts
    • Drug Discovery Biotechnology- R&D Spending Forecasts
    • Pre-clinical Spending- Biotechnology
  • Academic and Government Spending
    • Outline V
    • NIH Budget Historical
    • Academic and Government (NIH) R&D Spending
    • Government Funded Research Focus
  • Top 5 Agribiotech Spending
    • Outline VI
    • Top 5 Agribiotech Market Share
    • Top 5 Agribiotech- Revenue Forecasts
    • Top 5 Agribiotech- R&D Spending Forecasts
    • R&D Spending- Top 5 Agribiotech
  • Summary of R&D Spending
    • Outline VII
    • Total R&D Budget
    • Consumers of Research Products
    • Consumer Priorities
    • Key Market Engineering Measurements
  • Competitive Landscape
    • Outline VIII
    • VWR International
    • Fisher Scientific
    • Applied Biosystems
    • Sigma-Aldrich
    • Thermo Electron
    • Agilent Technologies
    • PerkinElmer
    • Waters Corporation
    • Millipore
    • Invitrogen
    • BD Biosciences
    • Qiagen
    • Beckman Coulter
    • Bio-Rad
    • GE Healthcare
  • Companies Affected by Changing Market Dynamics
    • Outline IX
    • Thermo-Fisher
    • Protein Design Labs
    • Exelixis
    • Ciphergen
    • Celera Genomics
    • Pharmacopeia
  • Decision Support Database
    • Outline X
    • Biotechnology Companies
    • Already known to 2010 and beyond
  • Frost & Sullivan Research Capabilities
    • Outline XI
    • Research Capabilities
Back to Top